S92G (p.Ser92Gly) variant of CDH2 (Cadherin-2)

S92G (p.Ser92Gly) in CDH2 (Cadherin-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes population frequency data and structural context.

S92G (p.Ser92Gly) variant details